PPD DEVELOPMENT LP - RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. CLINICAL STUDY PROTOCOL DEVELOPMENT. TASK ORDER 02. 06/17/2024 - 06/16/2029. BASE AND EXERCISE 2 UNITS OF OPTION QUANTITY 1.
Key Details
Description
RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. CLINICAL STUDY PROTOCOL DEVELOPMENT. TASK ORDER 02. 06/17/2024 - 06/16/2029. BASE AND EXERCISE 2 UNITS OF OPTION QUANTITY 1.
Context & Analysis
On Dec 12, 2025, Department of Health and Human Services obligated $324,420 to PPD DEVELOPMENT LP for research and development for clinical studies in the blueprint medtech. clinical study protocol development. task order 02. 06/17/2024 - 06/16/2029. base and exercise 2 units of option quantity 1.. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in WILMINGTON, NC. The contract is scheduled through Jun 16, 2029.
Contractor Information
Stay Updated
Get notified about new opportunities matching your interests.